BEISHUIZEN, Auke, Karin MELLGREN, Mara ANDRES, Anne AUPERIN, Chris M BACON, Simon BOMKEN, G A Amos BURKE, Birgit BURKHARDT, Laurence BRUGIERES, Alan K S CHIANG, Christine DAMM-WELK, Emanuele AMORE, Keizo HORIBE, Edita KABICKOVA, Tasneem KHANAM, Udo KONTNY, Wolfram KLAPPER, Laurence LAMANT, Le Deley MARIE-CECILE, Jan LOEFFEN, Elizabeth MACINTYRE, Georg MANN, Friederike MEYER-WENTRUP, Ulf MICHGEHL, Veronique MINARD-COLIN, Lara MUSSOLIN, Ilske OSCHLIES, Catherine PATTE, Marta PILLON, Alfred REITER, Charlotte RIGAUD, Leila RONCERY, Itziar SALAVERRIA, Ingrid SIMONITSCH-KLUPP, Anne UYTTEBROECK, Jaime VERDU-AMOROS, Denise WILLIAMS, Wilhelm WOESSMANN, Andrew WOTHERSPOON, Grazyna WROBEL, Martin ZIMMERMANN, Andishe ATTARBASCHI and Suzanne Dawn TURNER. Improving outcomes of childhood and young adult non-Hodgkin lymphoma: 25 years of research and collaboration within the framework of the European Intergroup for Childhood Non-Hodgkin Lymphoma. LANCET HAEMATOLOGY. Oxford: ELSEVIER SCI LTD, 2023, vol. 10, No 3, p. "E213"-"E224", 12 pp. ISSN 2352-3026. Available from: https://dx.doi.org/10.1016/S2352-3026(22)00374-X.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Improving outcomes of childhood and young adult non-Hodgkin lymphoma: 25 years of research and collaboration within the framework of the European Intergroup for Childhood Non-Hodgkin Lymphoma
Authors BEISHUIZEN, Auke, Karin MELLGREN, Mara ANDRES, Anne AUPERIN, Chris M BACON, Simon BOMKEN, G A Amos BURKE, Birgit BURKHARDT, Laurence BRUGIERES, Alan K S CHIANG, Christine DAMM-WELK, Emanuele AMORE, Keizo HORIBE, Edita KABICKOVA, Tasneem KHANAM, Udo KONTNY, Wolfram KLAPPER, Laurence LAMANT, Le Deley MARIE-CECILE, Jan LOEFFEN, Elizabeth MACINTYRE, Georg MANN, Friederike MEYER-WENTRUP, Ulf MICHGEHL, Veronique MINARD-COLIN, Lara MUSSOLIN, Ilske OSCHLIES, Catherine PATTE, Marta PILLON, Alfred REITER, Charlotte RIGAUD, Leila RONCERY, Itziar SALAVERRIA, Ingrid SIMONITSCH-KLUPP, Anne UYTTEBROECK, Jaime VERDU-AMOROS, Denise WILLIAMS, Wilhelm WOESSMANN, Andrew WOTHERSPOON, Grazyna WROBEL, Martin ZIMMERMANN, Andishe ATTARBASCHI and Suzanne Dawn TURNER (826 United Kingdom of Great Britain and Northern Ireland, belonging to the institution).
Edition LANCET HAEMATOLOGY, Oxford, ELSEVIER SCI LTD, 2023, 2352-3026.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30205 Hematology
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 24.700 in 2022
RIV identification code RIV/00216224:14740/23:00133642
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.1016/S2352-3026(22)00374-X
UT WoS 000955868100001
Keywords in English LARGE-CELL; LYMPHOMA; MINIMAL RESIDUAL DISEASE; BURKITTS-LYMPHOMA; GENE-EXPRESSION
Tags rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Eva Dubská, učo 77638. Changed: 26/2/2024 00:17.
Abstract
The European Intergroup for Childhood Non-Hodgkin Lymphoma (EICNHL) was established 25 years ago with the goal to facilitate clinical trials and research collaborations in the field both within Europe and worldwide. Since its inception, much progress has been made whereby major improvements in outcomes have been achieved. In this Review, we describe the different diagnostic entities of non-Hodgkin lymphoma in children and young adults describing key features of each entity and outlining clinical achievements made in the context of the EICNHL framework. Furthermore, we provide an overview of advances in biopathology with an emphasis on the role of biological studies and how they have shaped available treatments. Finally, for each entity, we describe future goals, upcoming clinical trials, and highlight areas of research that require our focus going forward.
PrintDisplayed: 1/10/2024 10:41